(Hypertension. 1995;25:744-747.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Geriatric Medicine, Osaka University Medical School, and Tsukuba Research Institute, Banyu Pharmaceutical Co Ltd, Ibaraki (M.Y.), Japan.
Correspondence to Keisuke Fukuo, MD, Department of Geriatric Medicine, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565, Japan.
Abstract Prolonged incubation with 1 nmol/L interleukin-1 induced high levels of nitric oxide release and cytotoxicity in vascular smooth muscle cells. NG-Monomethyl-L-arginine, an inhibitor of nitric oxide synthesis, inhibited interleukin-1induced cytotoxicity at a concentration of 3 mmol/L. Furthermore, prolonged incubation with 0.1 mmol/L sodium nitroprusside, a nitric oxide donor, also induced cytotoxicity. On the other hand, endothelin-1 at concentrations from 10-10 to 10-7 mol/L induced a concentration-dependent enhancement of cytotoxicity induced by interleukin-1. However, endothelin-1 did not affect interleukin-1induced nitric oxide production. Coculture study of vascular smooth muscle cells and endothelial cells without direct cell contact revealed that incubation for 72 hours with interleukin-1 induced high levels of nitric oxide release from cocultured vascular smooth muscle cells to the same degree as release from vascular smooth muscle cells alone. However, interleukin-1induced cytotoxicity was more enhanced in cocultured vascular smooth muscle cells than in vascular smooth muscle cells alone. Furthermore, coincubation with 20 nmol/L BQ-485, an antagonist of one type of endothelin receptor (ETA), prevented the enhancement of interleukin-1induced cytotoxicity in cocultured vascular smooth muscle cells. These findings suggest that endothelin-1 secreted from endothelial cells may enhance nitric oxideinduced cytotoxicity by means of the ETA receptor in vascular smooth muscle cells.
Key Words: nitric oxide cytotoxins muscle, smooth, vascular endothelins receptors, endothelin
This article has been cited by other articles:
![]() |
Y. FUJII, S. MAGDER, P. CERNACEK, P. GOLDBERG, Y. GUO, and S. N. A. HUSSAIN Endothelin Receptor Blockade Attenuates Lipopolysaccharide-induced Pulmonary Nitric Oxide Production Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 982 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Allaire and A. W. Clowes Endothelial Cell Injury in Cardiovascular Surgery: The Intimal Hyperplastic Response Ann. Thorac. Surg., February 1, 1997; 63(2): 582 - 591. [Abstract] [Full Text] |
||||
![]() |
U. Ikeda, K. Yamamoto, Y. Maeda, M. Shimpo, T. Kanbe, and K. Shimada Endothelin-1 Inhibits Nitric Oxide Synthesis in Vascular Smooth Muscle Cells Hypertension, January 1, 1997; 29(1): 65 - 69. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |